Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Autor:	Jain, Tania, Bar, Merav, Kansagra, Ankit J., Chong, Elise A., Hashmi, Shahrukh K., Neelapu, Sattva S., Byrne, Michael, Jacoby, Elad, Lazaryan, Aleksandr, Jacobson, Caron A., Ansell, Stephen M., Awan, Farrukh T., Burns, Linda, Bachanova, Veronika, Bollard, Catherine M., Carpenter, Paul A., DiPersio, John F., Hamadani, Mehdi, Heslop, Helen E., Hill, Joshua A., Komanduri, Krishna V., Kovitz, Craig A., Lazarus, Hillard M., Serrette, Justin M., Mohty, Mohamad, Miklos, David, Nagler, Arnon, Pavletic, Steven Z., Savani, Bipin N., Schuster, Stephen J., Kharfan-Dabaja, Mohamed A., Perales, Miguel-Angel, Lin, Yi
Zdroj:	In Biology of Blood and Marrow Transplantation December 2019 25(12):2305-2321
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect